Market Overview:
The global transcriptomics technologies market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for clinical diagnostics, drug discovery and research, and bioinformatics applications. Additionally, the growing focus on comparative transcriptomics studies is also contributing to the growth of the market. The microarrays segment is expected to hold the largest share of the global transcriptomics technologies market in 2018. This segment is anticipated to grow at a CAGR of 11% duringthe forecast period.
Product Definition:
The study of gene expression patterns in transcriptomes. Transcriptomics technologies are important for understanding the function of genes and how they are regulated.
Microarrays:
Microarrays is a new technology that has evolved from array microbiology. Microarray allows the detection of gene expression by using probes or molecules which are attached to an array, these arrays are then exposed to the sample and if there is any response then it will be detected. The most common types of microarrays include cDNA microarray and protein microarray.
Polymerase Chain Reaction (PCR):
Polymerase chain reaction (PCR) is a technique that enables multiple copies of a specific DNA sequence to be generated from a single original DNA molecule. The process has gained immense popularity in recent years due to its ability to generate millions of copies of an oligonucleotide within minutes. This technology has been used effectively for the quantification and analysis of gene expression, which has led to its increasing application in transcriptomics technologies market.
Application Insights:
Drug discovery and research application segment led the market in 2017. This is attributed to factors such as an increase in government funding for drug development, rise in demand for targeted drugs by pharmaceutical companies, and growing emphasis of pharmaceutical companies on drug screening and development. Moreover, transcriptomics plays a significant role in discovering new targets that can be used for the diagnosis or treatment of diseases. For instance, studies have shown that Transcriptor-Based Screening (TBS) can be used to screen millions of compounds/RNAs at once with high specificity and sensitivity. Thus TBS is being widely adopted by various organizations involved in cancer research such as The Cancer Genome Atlas (TCGA).
The clinical diagnostics segment is expected to witness lucrative growth over the forecast period due to rising adoption of NGS technology across diagnostic laboratories worldwide coupled with increasing R&D investments by manufacturers of genetic analysis tools & solutions.
Regional Analysis:
North America dominated the global transcriptomics technologies market in 2017. This is due to the presence of a well-established research framework for genomics studies, which supports ongoing clinical trials and enables easy access to high-quality genomic data. Moreover, government funding for R&D in this field has increased significantly over the years, which has led to an increase in adoption of these technologies across several academic institutes and biopharmaceutical companies based in this region.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing investments by governments as well as private players towards development of novel therapeutics and vaccines using Transcriptor Analysis Services (TAS). Furthermore, growing awareness about early diagnosis among patients will also boost demand for NGS platforms such as Illumina’s Genome Analyzer series that are used for whole genome amplification (WGA) followed by analysis on an Illumina platform.
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in transcriptomics technologies
- Growing investments in life sciences research and development
- Rising number of collaborations and partnerships between pharmaceutical companies and biotechnology firms
Scope Of The Report
Report Attributes
Report Details
Report Title
Transcriptomics Technologies Market Research Report
By Type
Microarrays, Polymerase Chain Reaction (PCR), Gene Regulation Technologies, Next Generation Sequencing (NGS)
By Application
Clinical Diagnostics, Drug Discovery and Research, Bioinformatics, Comparative Transcriptomics Studies
By Companies
Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., Life Technologies Corporation, Qiangen N.V., LC Sciences, Sigma-Aldrich Corp, Danaher Corp
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global Transcriptomics Technologies Market Report Segments:
The global Transcriptomics Technologies market is segmented on the basis of:
Types
Microarrays, Polymerase Chain Reaction (PCR), Gene Regulation Technologies, Next Generation Sequencing (NGS)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Clinical Diagnostics, Drug Discovery and Research, Bioinformatics, Comparative Transcriptomics Studies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Affymetrix, Inc.
- Thermo Fisher Scientific
- Agilent Technologies
- F-Hoffmann La Roche Ltd.
- Illumina, Inc.
- Life Technologies Corporation
- Qiangen N.V.
- LC Sciences
- Sigma-Aldrich Corp
- Danaher Corp
Highlights of The Transcriptomics Technologies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Microarrays
- Polymerase Chain Reaction (PCR)
- Gene Regulation Technologies
- Next Generation Sequencing (NGS)
- By Application:
- Clinical Diagnostics
- Drug Discovery and Research
- Bioinformatics
- Comparative Transcriptomics Studies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Transcriptomics Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Transcriptomics technologies are a set of methods used to study the transcriptome, which is the totality of all RNA molecules expressed in a cell or organism. Transcriptomics can be used to identify and characterize genes and gene products, as well as to track changes in gene expression over time.
Some of the major players in the transcriptomics technologies market are Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., Illumina, Inc., Life Technologies Corporation, Qiangen N.V., LC Sciences, Sigma-Aldrich Corp, Danaher Corp.
The transcriptomics technologies market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Transcriptomics Technologies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Transcriptomics Technologies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Transcriptomics Technologies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Transcriptomics Technologies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Transcriptomics Technologies Market Size & Forecast, 2018-2028
4.5.1 Transcriptomics Technologies Market Size and Y-o-Y Growth
4.5.2 Transcriptomics Technologies Market Absolute $ Opportunity
Chapter 5 Global Transcriptomics Technologies Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Transcriptomics Technologies Market Size Forecast by Type
5.2.1 Microarrays
5.2.2 Polymerase Chain Reaction (PCR)
5.2.3 Gene Regulation Technologies
5.2.4 Next Generation Sequencing (NGS)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Transcriptomics Technologies Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Transcriptomics Technologies Market Size Forecast by Applications
6.2.1 Clinical Diagnostics
6.2.2 Drug Discovery and Research
6.2.3 Bioinformatics
6.2.4 Comparative Transcriptomics Studies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Transcriptomics Technologies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Transcriptomics Technologies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Transcriptomics Technologies Analysis and Forecast
9.1 Introduction
9.2 North America Transcriptomics Technologies Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Transcriptomics Technologies Market Size Forecast by Type
9.6.1 Microarrays
9.6.2 Polymerase Chain Reaction (PCR)
9.6.3 Gene Regulation Technologies
9.6.4 Next Generation Sequencing (NGS)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Transcriptomics Technologies Market Size Forecast by Applications
9.10.1 Clinical Diagnostics
9.10.2 Drug Discovery and Research
9.10.3 Bioinformatics
9.10.4 Comparative Transcriptomics Studies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Transcriptomics Technologies Analysis and Forecast
10.1 Introduction
10.2 Europe Transcriptomics Technologies Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Transcriptomics Technologies Market Size Forecast by Type
10.6.1 Microarrays
10.6.2 Polymerase Chain Reaction (PCR)
10.6.3 Gene Regulation Technologies
10.6.4 Next Generation Sequencing (NGS)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Transcriptomics Technologies Market Size Forecast by Applications
10.10.1 Clinical Diagnostics
10.10.2 Drug Discovery and Research
10.10.3 Bioinformatics
10.10.4 Comparative Transcriptomics Studies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Transcriptomics Technologies Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Transcriptomics Technologies Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Transcriptomics Technologies Market Size Forecast by Type
11.6.1 Microarrays
11.6.2 Polymerase Chain Reaction (PCR)
11.6.3 Gene Regulation Technologies
11.6.4 Next Generation Sequencing (NGS)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Transcriptomics Technologies Market Size Forecast by Applications
11.10.1 Clinical Diagnostics
11.10.2 Drug Discovery and Research
11.10.3 Bioinformatics
11.10.4 Comparative Transcriptomics Studies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Transcriptomics Technologies Analysis and Forecast
12.1 Introduction
12.2 Latin America Transcriptomics Technologies Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Transcriptomics Technologies Market Size Forecast by Type
12.6.1 Microarrays
12.6.2 Polymerase Chain Reaction (PCR)
12.6.3 Gene Regulation Technologies
12.6.4 Next Generation Sequencing (NGS)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Transcriptomics Technologies Market Size Forecast by Applications
12.10.1 Clinical Diagnostics
12.10.2 Drug Discovery and Research
12.10.3 Bioinformatics
12.10.4 Comparative Transcriptomics Studies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Transcriptomics Technologies Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Transcriptomics Technologies Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Transcriptomics Technologies Market Size Forecast by Type
13.6.1 Microarrays
13.6.2 Polymerase Chain Reaction (PCR)
13.6.3 Gene Regulation Technologies
13.6.4 Next Generation Sequencing (NGS)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Transcriptomics Technologies Market Size Forecast by Applications
13.10.1 Clinical Diagnostics
13.10.2 Drug Discovery and Research
13.10.3 Bioinformatics
13.10.4 Comparative Transcriptomics Studies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Transcriptomics Technologies Market: Competitive Dashboard
14.2 Global Transcriptomics Technologies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Affymetrix, Inc.
14.3.2 Thermo Fisher Scientific
14.3.3 Agilent Technologies
14.3.4 F-Hoffmann La Roche Ltd.
14.3.5 Illumina, Inc.
14.3.6 Life Technologies Corporation
14.3.7 Qiangen N.V.
14.3.8 LC Sciences
14.3.9 Sigma-Aldrich Corp
14.3.10 Danaher Corp
